Cargando…
Illuminating the mechanism of IL-6-mediated immunotherapy resistance
Huseni et al. report that IL-6-STAT3 signaling negatively impacts the anti-tumor function of cytotoxic T cells. Targeting IL-6 signaling may enhance tumor responses to immune checkpoint blockade therapy.
Autor principal: | Vilgelm, Anna E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873941/ https://www.ncbi.nlm.nih.gov/pubmed/36652910 http://dx.doi.org/10.1016/j.xcrm.2022.100901 |
Ejemplares similares
-
Illuminating the Fc dependence of SARS-CoV-2 neutralization
por: González, Joseph C., et al.
Publicado: (2021) -
T cell biomarkers come to the fore in cancer immunotherapy
por: Sheriff, Lozan, et al.
Publicado: (2023) -
Discover immunotherapy biomarkers from single-cell cytometry data
por: Ru, Beibei, et al.
Publicado: (2021) -
Inhibition of S6K by resveratrol: In search of the purpose
por: Blagosklonny, Mikhail V.
Publicado: (2009) -
Sirtuins
at the Breaking Point: SIRT6 in DNA Repair
por: Lombard, David B.
Publicado: (2009)